Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C
Concerns about reinfection may be limiting HCV treatment uptake among people who use drugs (PWUD), with rates of 17.1/100 person-years in...
top of page
COVID-19 & Sports
COVID-19 & Sports
COVID-19 & Sports
Published Work
From observational studies to clinical trials, the VIDC research team shares our findings with the medical community at international conferences.
​
Visit us at an upcoming conference >
bottom of page